Literature DB >> 27858211

Factors Influencing the Decision-Making Process and Long-Term Interpersonal Outcomes for Parents Who Undergo Preimplantation Genetic Diagnosis for Fanconi Anemia: a Qualitative Investigation.

K Haude1, P McCarthy Veach2, B LeRoy2, H Zierhut3.   

Abstract

Fanconi anemia (FA) is characterized by congenital malformations, progressive bone marrow failure, and predisposition to malignancy. Hematopoietic stem cell transplantation is used to treat FA, and best results are attained with sibling donors who are human leukocyte antigen (HLA) identical matches. Preimplantation genetic diagnosis (PGD) offers parents of an affected child the opportunity to have an unaffected child who is an HLA match. While some research has investigated parents' experiences during the PGD process, no published studies specifically address factors influencing their decision-making process and long-term interpersonal outcomes. The aims of this study are to: (1) examine parents' expectations and the influence of media, bioethics, and religion on their decision to undergo PGD; (2) examine parents' social support and emotional experiences during their PGD process; and (3) characterize long-term effects of PGD on relationship dynamics (partner, family, friends), others' attitudes, and parental regret. Nine parents participated in semi-structured interviews. Thematic analysis revealed their decision to use PGD was variously influenced by media, bioethics, and religion, in particular, affecting parents' initial confidence levels. Moreover, the PGD process was emotionally complex, with parents desiring varying amounts and types of support from different sources at different times. Parents reported others' attitudes towards them were similar or no different than before PGD. Parental regret regarding PGD was negligible. Results of this study will promote optimization of long-term care for FA families.

Entities:  

Keywords:  Decision-making; Decisional regret; Fanconi anemia; Human leukocyte antigen; Long-term interpersonal outcomes; Parents; Preimplantation genetic diagnosis

Mesh:

Year:  2016        PMID: 27858211     DOI: 10.1007/s10897-016-0032-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  36 in total

1.  Social networks, social support mechanisms, and quality of life after breast cancer diagnosis.

Authors:  Candyce H Kroenke; Marilyn L Kwan; Alfred I Neugut; Isaac J Ergas; Jaime D Wright; Bette J Caan; Dawn Hershman; Lawrence H Kushi
Journal:  Breast Cancer Res Treat       Date:  2013-05-09       Impact factor: 4.872

2.  Christian lay understandings of preimplantation genetic diagnosis.

Authors:  Bill Doolin; Judy Motion
Journal:  Public Underst Sci       Date:  2010-11

3.  The ART of social networking: how SART member clinics are connecting with patients online.

Authors:  Kenan Omurtag; Patricia T Jimenez; Valerie Ratts; Randall Odem; Amber R Cooper
Journal:  Fertil Steril       Date:  2011-11-14       Impact factor: 7.329

4.  A prospective study assessing anxiety, depression and maternal-fetal attachment in women using PGD.

Authors:  J C Karatas; K Barlow-Stewart; B Meiser; C McMahon; K A Strong; W Hill; C Roberts; P J Kelly
Journal:  Hum Reprod       Date:  2010-10-19       Impact factor: 6.918

5.  Should selecting saviour siblings be banned?

Authors:  S Sheldon; S Wilkinson
Journal:  J Med Ethics       Date:  2004-12       Impact factor: 2.903

6.  Savior siblings, parenting and the moral valorization of children.

Authors:  Kimberly Strong; Ian Kerridge; Miles Little
Journal:  Bioethics       Date:  2012-07-29       Impact factor: 1.898

7.  Effects of social relationships on survival for women with breast cancer: a prospective study.

Authors:  N Waxler-Morrison; T G Hislop; B Mears; L Kan
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

8.  Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis.

Authors:  Satkiran S Grewal; Jeffrey P Kahn; Margaret L MacMillan; Norma K C Ramsay; John E Wagner
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

9.  Bone marrow transplantation for Fanconi anemia.

Authors:  E Gluckman; A D Auerbach; M M Horowitz; K A Sobocinski; R C Ash; M M Bortin; A Butturini; B M Camitta; R E Champlin; W Friedrich; R A Good; E C Gordon-Smith; R E Harris; J P Klein; J J Ortega; R Pasquini; N K Ramsay; B Speck; M R Vowels; M J Zhang; R P Gale
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

Review 10.  Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment.

Authors:  S Gameiro; J Boivin; L Peronace; C M Verhaak
Journal:  Hum Reprod Update       Date:  2012-08-06       Impact factor: 15.610

View more
  5 in total

1.  Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.

Authors:  Pnina Mor; Sarah Brennenstuhl; Kelly A Metcalfe
Journal:  J Genet Couns       Date:  2018-06-01       Impact factor: 2.537

2.  The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users.

Authors:  Shachar Zuckerman; Sigal Gooldin; David A Zeevi; Gheona Altarescu
Journal:  J Assist Reprod Genet       Date:  2020-05-27       Impact factor: 3.412

3.  Challenges, Dilemmas and Factors Involved in PGD Decision-Making: Providers' and Patients' Views, Experiences and Decisions.

Authors:  Robert Klitzman
Journal:  J Genet Couns       Date:  2017-12-16       Impact factor: 2.537

Review 4.  Fanconi Anaemia, Childhood Cancer and the BRCA Genes.

Authors:  Emma R Woodward; Stefan Meyer
Journal:  Genes (Basel)       Date:  2021-09-27       Impact factor: 4.096

5.  Comparison of Patients' Ethical Perspectives of Preimplantation Embryo Genetic Testing for Aneuploidy (PGT-A) vs. Monogenic Disorders (PGT-M).

Authors:  J Zhang; L R Rubin; H Zierhut; L M Pastore
Journal:  Reprod Sci       Date:  2021-06-15       Impact factor: 2.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.